| 65561 | |
| The incorporation of fluorine into fine chemicals has had a significant impact in the chemical, agrochemical, and pharmaceutical industries given nearly 20 percent of pharmaceuticals contain fluorine and significantly more agrochemicals contain fluorination. Fluoroform is a gas that is used in industrial processes, but it is a potent "greenhouse" gas. Because of this, the use of gaseous fluoroform must be strictly limited to prevent its unwanted escape into the atmosphere. Researchers at Purdue University have developed a new synthetic reagent and method for the mild and efficient preparation of fluorinated compounds. This simple and straightforward method can be accomplished by a novice chemist, at room temperature, in open air, and without the need for complicated inert atmosphere techniques. Among other intermediates, Purdue researchers validated this method through its use in the aldol and imino-aldol processes, the facile production of difluoroenolates, and the formation of alpha, alpha-difluorinated beta amino acids. Difluorinated molecules, such as beta amino acids, are important research tools and building blocks for drug discovery. Advantages: -Novel trifluoroacetate release strategy uses mild conditions (room temperature) -Generation of pharmaceutically important intermediates -Compatible with large scope of substrates Potential Applications: -Medical/Healthcare -Pharmaceuticals -Chemical Analysis -Drug Development |
|
|
|
|
Oct 16, 2013
NATL-Patent
United States
9,359,277
Jun 7, 2016
Mar 22, 2012
PCT-Patent
WO
(None)
(None)
Mar 25, 2011
Provisional-Patent
United States
(None)
(None)
Mar 22, 2011
Provisional-Patent
United States
(None)
(None)
Mar 22, 2010
Provisional-Patent
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |